{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:39:10Z","timestamp":1792075150306,"version":"4.4.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","cghjournal.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.cgh.2016.10.024","type":"journal-article","created":{"date-parts":[[2017,1,14]],"date-time":"2017-01-14T10:00:18Z","timestamp":1484388018000},"page":"166-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":139,"title":["Management of Clostridium difficile Infection in Inflammatory Bowel Disease: Expert Review from the Clinical Practice Updates Committee of the AGA Institute"],"prefix":"10.1016","volume":"15","author":[{"given":"Sahil","family":"Khanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciar\u00e1n P.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2016.10.024_bib1","first-page":"287","article-title":"Clostridium difficile infection","volume":"373","author":"Leffler","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2016.10.024_bib2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)","volume":"31","author":"Cohen","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cgh.2016.10.024_bib3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJM197803092981003","article-title":"Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia","volume":"298","author":"Bartlett","year":"1978","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2016.10.024_bib4","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0140-6736(78)90912-1","article-title":"Clostridium difficile and the aetiology of pseudomembranous colitis","volume":"1","author":"Larson","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2016.10.024_bib5","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMra0707500","article-title":"Clostridium difficile\u2013more difficult than ever","volume":"359","author":"Kelly","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2016.10.024_bib6","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa1408913","article-title":"Burden of Clostridium difficile infection in the United States","volume":"372","author":"Lessa","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2016.10.024_bib7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3201\/eid1205.051064","article-title":"Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003","volume":"12","author":"McDonald","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cgh.2016.10.024_bib8","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa051590","article-title":"An epidemic, toxin gene-variant strain of Clostridium difficile","volume":"353","author":"McDonald","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2016.10.024_bib9","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa051639","article-title":"A\u00a0predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality","volume":"353","author":"Loo","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2016.10.024_bib10","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/j.gastro.2009.02.073","article-title":"Clostridium difficile infection caused by the epidemic BI\/NAP1\/027 strain","volume":"136","author":"O'Connor","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2016.10.024_bib11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0140-6736(80)90939-3","article-title":"Therapeutic implications of Clostridium difficile toxin during relapse of chronic inflammatory bowel disease","volume":"1","author":"LaMont","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2016.10.024_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.crohns.2008.09.003","article-title":"Increasing incidence of Clostridium difficile-associated diarrhea in inflammatory bowel disease","volume":"3","author":"Bossuyt","year":"2009","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2016.10.024_bib13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cgh.2006.12.027","article-title":"Incidence of Clostridium difficile infection in inflammatory bowel disease","volume":"5","author":"Rodemann","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2016.10.024_bib14","first-page":"4","article-title":"Risk factors for Clostridium difficile diarrhea in patients with inflammatory bowel disease","volume":"107","author":"Ramos-Martinez","year":"2015","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.cgh.2016.10.024_bib15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cgh.2006.12.028","article-title":"Impact of Clostridium difficile on inflammatory bowel disease","volume":"5","author":"Issa","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2016.10.024_bib16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/gut.2007.128231","article-title":"Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease","volume":"57","author":"Ananthakrishnan","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2016.10.024_bib17","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/j.1572-0241.2007.01780.x","article-title":"A\u00a0national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients","volume":"103","author":"Nguyen","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2016.10.024_bib18","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1097\/MIB.0000000000000461","article-title":"Pathogenesis of Clostridium difficile infection and its potential role in inflammatory bowel disease","volume":"21","author":"Monaghan","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2016.10.024_bib19","doi-asserted-by":"crossref","first-page":"e0146822","DOI":"10.1371\/journal.pone.0146822","article-title":"Identification of Medicare recipients at highest risk for Clostridium difficile infection in the US by population attributable risk analysis","volume":"11","author":"Dubberke","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2016.10.024_bib20","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1056\/NEJM200002103420604","article-title":"Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A","volume":"342","author":"Kyne","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2016.10.024_bib21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/ajg.2011.404","article-title":"Editorial: not so nosocomial anymore: the growing threat of community-acquired Clostridium difficile","volume":"107","author":"Leffler","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2016.10.024_bib22","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/ajg.2009.4","article-title":"The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission","volume":"104","author":"Clayton","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2016.10.024_bib23","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1053\/j.gastro.2014.02.009","article-title":"The microbiome in inflammatory bowel disease: current status and the future ahead","volume":"146","author":"Kostic","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2016.10.024_bib24","doi-asserted-by":"crossref","first-page":"13780","DOI":"10.1073\/pnas.0706625104","article-title":"Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases","volume":"104","author":"Frank","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cgh.2016.10.024_bib25","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/gutjnl-2013-304833","article-title":"A\u00a0decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis","volume":"63","author":"Machiels","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2016.10.024_bib26","doi-asserted-by":"crossref","first-page":"e8740","DOI":"10.1371\/journal.pone.0008740","article-title":"Metabolism of bile salts in mice influences spore germination in Clostridium difficile","volume":"5","author":"Giel","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2016.10.024_bib27","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/apt.13616","article-title":"Recurrent Clostridium difficile infection associates with distinct bile acid and microbiome profiles","volume":"43","author":"Allegretti","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2016.10.024_bib28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(00)03592-3","article-title":"Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea","volume":"357","author":"Kyne","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2016.10.024_bib29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1056\/NEJMoa0907635","article-title":"Treatment with monoclonal antibodies against Clostridium difficile toxins","volume":"362","author":"Lowy","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2016.10.024_bib30","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10620-009-0749-9","article-title":"Clinical outcomes of patients with ulcerative colitis and co-existing Clostridium difficile infection","volume":"55","author":"Jodorkovsky","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2016.10.024_bib31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrgastro.2012.87","article-title":"IBD: poor outcomes after Clostridium difficile infection in IBD","volume":"9","author":"Khanna","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2016.10.024_bib32","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/j.gastro.2008.12.038","article-title":"Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection","volume":"136","author":"Hu","year":"2009","journal-title":"Gastroenterology"},{"issue":"Suppl 6","key":"10.1016\/j.cgh.2016.10.024_bib33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/1469-0691.12046","article-title":"Can we identify patients at high risk of recurrent Clostridium difficile infection?","volume":"18","author":"Kelly","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cgh.2016.10.024_bib34","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jhin.2008.08.012","article-title":"Meta-analysis to assess risk factors for recurrent Clostridium difficile infection","volume":"70","author":"Garey","year":"2008","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.cgh.2016.10.024_bib35","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/ajg.2016.187","article-title":"Recurrence of Clostridium difficile infection in patients with inflammatory bowel disease: the RECIDIVISM study","volume":"111","author":"Razik","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2016.10.024_bib36","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ajg.2013.4","article-title":"Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections","volume":"108","author":"Surawicz","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 2","key":"10.1016\/j.cgh.2016.10.024_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12418","article-title":"European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection","volume":"20","author":"Debast","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cgh.2016.10.024_bib38","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1086\/521854","article-title":"Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents","volume":"45","author":"Riggs","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2016.10.024_bib39","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1186\/s12879-015-1258-4","article-title":"Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications","volume":"15","author":"Furuya-Kanamori","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cgh.2016.10.024_bib40","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/cid\/ciu258","article-title":"Prevalence and risk factors for asymptomatic Clostridium difficile carriage","volume":"59","author":"Alasmari","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2016.10.024_bib41","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S1473-3099(13)70200-7","article-title":"Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection","volume":"13","author":"Planche","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cgh.2016.10.024_bib42","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1001\/jamainternmed.2015.4114","article-title":"Overdiagnosis of Clostridium difficile infection in the molecular test era","volume":"175","author":"Polage","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cgh.2016.10.024_bib43","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ajg.2013.4","article-title":"Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections","volume":"108","author":"Surawicz","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2016.10.024_bib44","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/519265","article-title":"A\u00a0comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity","volume":"45","author":"Zar","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2016.10.024_bib45","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1086\/430315","article-title":"Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada","volume":"40","author":"Pepin","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2016.10.024_bib46","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1086\/430311","article-title":"Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole","volume":"40","author":"Musher","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2016.10.024_bib47","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/cid\/ciu313","article-title":"Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials","volume":"59","author":"Johnson","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2016.10.024_bib48","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa0910812","article-title":"Fidaxomicin versus vancomycin for Clostridium difficile infection","volume":"364","author":"Louie","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2016.10.024_bib49","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/cid\/cir404","article-title":"Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections","volume":"53","author":"Mullane","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2016.10.024_bib50","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/cid\/cit346","article-title":"Is fidaxomicin worth the cost? An economic analysis","volume":"57","author":"Bartsch","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cgh.2016.10.024_bib51","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1128\/AAC.02606-13","article-title":"Antibiotics for treatment of Clostridium difficile infection in hospitalized patients with inflammatory bowel disease","volume":"58","author":"Horton","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cgh.2016.10.024_bib52","doi-asserted-by":"crossref","first-page":"S744","DOI":"10.1016\/S0016-5085(16)32527-6","article-title":"Outcomes of fidaxomicin treatment of Clostridium difficile infection","volume":"150","author":"Spiceland","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2016.10.024_bib53","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/j.1365-2036.2011.04661.x","article-title":"Increased health burden associated with Clostridium difficile diarrhoea in patients with inflammatory bowel disease","volume":"33","author":"Jen","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2016.10.024_bib54","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/j.gastro.2015.05.008","article-title":"Update on fecal microbiota transplantation 2015: indications, methodologies, mechanisms, and outlook","volume":"149","author":"Kelly","year":"2015","journal-title":"Gastroenterology"},{"issue":"Suppl 3","key":"10.1016\/j.cgh.2016.10.024_bib55","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1002\/jhm.1909","article-title":"Current strategies for management of initial Clostridium difficile infection","volume":"7","author":"Kelly","year":"2012","journal-title":"J\u00a0Hosp Med"},{"key":"10.1016\/j.cgh.2016.10.024_bib56","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ajg.2014.133","article-title":"Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients","volume":"109","author":"Kelly","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2016.10.024_bib57","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.cgh.2016.02.018","article-title":"Inflammatory bowel disease affects the outcome of fecal microbiota transplantation for recurrent Clostridium difficile infection","volume":"14","author":"Khoruts","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2016.10.024_bib58","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/ecco-jcc\/jjv203","article-title":"Donor species richness determines faecal microbiota transplantation success in inflammatory bowel disease","volume":"10","author":"Vermeire","year":"2016","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2016.10.024_bib59","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.cgh.2009.05.031","article-title":"Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and clostridium difficile infection","volume":"7","author":"Ben-Horin","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2016.10.024_bib60","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1365-2036.2012.05022.x","article-title":"Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease","volume":"35","author":"Ananthakrishnan","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2016.10.024_bib61","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/ibd.21514","article-title":"Practice of gastroenterologists in treating flaring inflammatory bowel disease patients with clostridium difficile: antibiotics alone or combined antibiotics\/immunomodulators?","volume":"17","author":"Yanai","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2016.10.024_bib62","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/ibd.20500","article-title":"Clostridium difficile and inflammatory bowel disease","volume":"14","author":"Issa","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2016.10.024_bib63","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1159\/000233297","article-title":"Therapy- and non-therapy-dependent infectious complications in inflammatory bowel disease","volume":"27","author":"Epple","year":"2009","journal-title":"Dig Dis"}],"updated-by":[{"DOI":"10.1016\/j.cgh.2017.01.023","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000}}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356516309892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356516309892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T11:21:04Z","timestamp":1568719264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356516309892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1542356516309892"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2016.10.024","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Clostridium difficile Infection in Inflammatory Bowel Disease: Expert Review from the Clinical Practice Updates Committee of the AGA Institute","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2016.10.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the AGA Institute","name":"copyright","label":"Copyright"}]}}